Qiao Yin

Suzhou, 215004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention.

The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention.

Journal: EBioMedicine

Published: December 23, 2025

Panacis Quinquefolii Radix Polysaccharides Alleviate Depressive-Like Behaviors in Chronic Unpredictable Mild Stress-Induced Mice by Suppressing Complement C1Q/C3-Mediated Microglial Synaptic Pruning and Modulating Gut Microbiota.

Panacis Quinquefolii Radix Polysaccharides Alleviate Depressive-Like Behaviors in Chronic Unpredictable Mild Stress-Induced Mice by Suppressing Complement C1Q/C3-Mediated Microglial Synaptic Pruning and Modulating Gut Microbiota.

Journal: CNS neuroscience & therapeutics

Published: November 21, 2025

Astrocyte-derived complement C3 facilitated microglial phagocytosis of synapses in Staphylococcus aureus-associated neurocognitive deficits.

Astrocyte-derived complement C3 facilitated microglial phagocytosis of synapses in Staphylococcus aureus-associated neurocognitive deficits.

Journal: PLoS pathogens

Published: August 24, 2024

Sweet enhancers of polymerase chain reaction.

Sweet enhancers of polymerase chain reaction.

Journal: PloS one

Published: May 10, 2024

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus.

Exosomes as Emerging Regulators of Immune Responses in Type 2 Diabetes Mellitus.

Journal: Journal of diabetes research

Published: September 09, 2023

Molecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning.

Molecular mechanisms underlying microglial sensing and phagocytosis in synaptic pruning.

Journal: Neural regeneration research

Published: April 15, 2023

Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases.

Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases.

Journal: Genes & diseases

Published: October 27, 2022

Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson's disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation.

Botulinum neurotoxin A ameliorates depressive-like behavior in a reserpine-induced Parkinson's disease mouse model via suppressing hippocampal microglial engulfment and neuroinflammation.

Journal: Acta pharmacologica Sinica

Published: August 28, 2022

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson's disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment.

Preclinical reserpine models recapitulating motor and non-motor features of Parkinson's disease: Roles of epigenetic upregulation of alpha-synuclein and autophagy impairment.

Journal: Frontiers in pharmacology

Published: May 15, 2022

Clinical implications of exosome-derived noncoding RNAs in liver.

Clinical implications of exosome-derived noncoding RNAs in liver.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: July 16, 2021

Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.

Discovery and Rational Design of Natural-Product-Derived 2-Phenyl-3,4-dihydro-2H-benzo[f]chromen-3-amine Analogs as Novel and Potent Dipeptidyl Peptidase 4 (DPP-4) Inhibitors for the Treatment of Type 2 Diabetes.

Journal: Journal of medicinal chemistry

Published: July 12, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026